D3 lymph node dissection in gastric cancer: Evaluation of postoperative mortality and complications

Surgery Today

Volumn 30, Issue 8, 2000, Pages 700-705

  Günther, Klaus ^a   Horbach, Thomas ^a   Merkel, Susanne ^a   Meyer, Martin ^a   Schnell, Ute ^a   Klein, Peter ^a   Hohenberger, Werner ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Complications; Gastric cancer; Lymph node dissection; Mortality

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; DRAIN; HISTOPATHOLOGY; HUMAN; LENGTH OF STAY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; STOMACH CANCER; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0033846643     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950070080     Document Type: Article

References (15)

1. Epidemiology of gastric cancer
2. Surgical management of gastric adenocarcinoma
3. The general rules for the gastric cancer study in surgery and pathology
4. Surgical treatment for gastric cancer: The Japanese approach
5. Extended lymph node dissection for gastric cancer: Results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases
6. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan
7. Gastric Cancer
8. Survival benefit of extended D2 resection for proximal gastric cancer
9. Systematic extended lymph node dissection in curative therapy of stomach cancer
10. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma
11. Prognostic factors in gastric carcinoma - Results of the German gastric carcinoma study 1992
12. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group
13. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group
14. Proximal subtotal gastrectomy for the treatment of carcinoma of the upper third of the stomach: Its indications based on lymph node metastasis and perigastric lymphatic flow
15. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis